Genetic prion disease caused by PRNP Q160X mutation presenting with an orbitofrontal syndrome, cyclic diarrhea, and peripheral neuropathy

Manuscript Number: 

16-0300R1

Author(s): 
Jee Bang, Giovanni Coppola, Jamie C. Fong, Sven Forner, Michael D. Geschwind, Carrie K. Grouse, Anna M. Karydas, Andrea Legati, Bruce L. Miller, Zachary A. Miller, Jeffrey Ralph, Katherine J. Rankin, Julio C. Rojas

Disclosures

Jee Bang

  • Nothing to Disclose

Giovanni Coppola

  • Grants
    • Agency: 
      Takeda
      Dates: 
      2012-2016

Jamie C. Fong

  • Nothing to Disclose

Sven Forner

  • Nothing to Disclose

Michael D. Geschwind

  • Consulting Fees:
    Consulting: Gerson Lehrman Group, MedaCorp, Guidepoint Global, Best Doctors, Inc; Advanced Medical Inc., Quest Diagnostics, Franciscan Physician Network, Lewis Brisbois, Bisgaard & Smith LLP, Biohaven Pharma (Advisory Board meeting), Optio Inc., Honorarium: multiple grand rounds consulting; Oakstone Publishing, Inc.;
    Patents/Royalties
    I have done medical legal consulting.
    Grants
    • Agency: 
      Quest Diagnostics, Inc.
      Dates: 
      2015-2016

Carrie K. Grouse

  • Nothing to Disclose

Anna M. Karydas

  • Nothing to Disclose

Andrea Legati

  • Nothing to Disclose

Zachary A. Miller

  • Nothing to Disclose

Bruce L. Miller

  • Consulting Fees:
    The Tau Consortium The John Douglas French Foundation The Larry L. Hillblom Foundation, Medical Advisory Board National Institute for Health Research Cambridge Biomedical Research Centre and its subunit, the Biomedical Research Unit in Dementia (UK) External Advisor, University of Washington ADRC External Advisor, Stanford University ADRC External Advisor, University of Pittsburgh ADRC External Advisor, Arizona Alzheimer’s Disease Center (ADC)

Jeffrey Ralph

  • Nothing to Disclose

Katherine J. Rankin

  • Grants
    • Agency: 
      Quest Diagnostics, Inc.
      Dates: 
      12/01/2014 - 03/29/2017

Julio C. Rojas

  • Nothing to Disclose